Webcast

HeraMED Limited Investor Briefing – 9 June

June 9, 2021

HeraMED Limited Investor Briefing – 9 June

HeraMED Limited (ASX: HMD) Webcast Replay

HeraMED (ASX: HMD) is an innovative medical technology company leading the digital transformation of maternity care and developing pregnancy monitoring solutions for home use.

As a part of our ‘The Insiders: Meet the CEOs’ series, CEO & Co-Founder David Groberman, provides valuable insights to the company, its key markets and industry, and future prospects.

Recorded on 9 June 2021 at 12pm (AEST).

Join the next The Insider: Meet the CEOs webcast

Speak to the Reach Markets team

FEATURED SPEAKER

David Groberman

CEO & Co-Founder - HeraMED Limited (ASX: HMD)

HeraMED (ASX: HMD) is an innovative medical technology company leading the digital transformation of maternity care and developing pregnancy monitoring solutions for home use.

Harnessing state-of-the-art technology with superior UX/UI, they are creating solutions that are medically accurate, scientifically optimized, safe and affordable. HeraMED offers a proprietary platform that’s reshaping the Doctor/Patient relationship, using its clinically validated in-home foetal and maternal heart rate monitor, cloud computing, artificial intelligence and social networking dashboard.

Speak to the Reach Markets team



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.